BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,878,056 | -90.6% | 49,763 | -88.6% | 0.02% | -87.4% |
Q2 2023 | $19,905,893 | +7.9% | 436,916 | -3.9% | 0.18% | -2.2% |
Q1 2023 | $18,449,162 | -25.3% | 454,861 | -6.2% | 0.18% | -30.6% |
Q4 2022 | $24,709,033 | -99.8% | 484,776 | +86.0% | 0.26% | +68.6% |
Q3 2022 | $14,039,632,000 | +84711.1% | 260,669 | +1.1% | 0.15% | -6.7% |
Q2 2022 | $16,554,000 | -18.7% | 257,729 | -1.8% | 0.16% | +4.5% |
Q1 2022 | $20,353,000 | -55.3% | 262,484 | -50.5% | 0.16% | -7.1% |
Q4 2021 | $45,550,000 | +141.6% | 530,634 | +126.3% | 0.17% | -13.8% |
Q3 2021 | $18,857,000 | +21.4% | 234,447 | +21.5% | 0.20% | +13.3% |
Q2 2021 | $15,528,000 | -1.5% | 192,894 | +3.2% | 0.17% | -14.4% |
Q1 2021 | $15,761,000 | +5.0% | 186,874 | -0.1% | 0.20% | -1.0% |
Q4 2020 | $15,015,000 | +1.8% | 187,127 | +2.0% | 0.20% | -8.5% |
Q3 2020 | $14,749,000 | +41.4% | 183,395 | +51.4% | 0.22% | +27.4% |
Q2 2020 | $10,433,000 | +5.9% | 121,170 | -0.2% | 0.18% | -13.8% |
Q1 2020 | $9,855,000 | +15.0% | 121,387 | +18.4% | 0.20% | +36.2% |
Q4 2019 | $8,570,000 | +31.3% | 102,491 | +37.4% | 0.15% | +20.2% |
Q3 2019 | $6,525,000 | +12.8% | 74,601 | +5.6% | 0.12% | +17.0% |
Q2 2019 | $5,784,000 | +0.6% | 70,627 | -0.2% | 0.11% | -3.6% |
Q1 2019 | $5,752,000 | – | 70,747 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |